Funding and Support
FDA Broad Agency Announcement for the Advanced Research and Development of Regulatory Science
The U.S. Food and Drug Administration has an open, continuing announcement to solicit research and development in support of regulatory science and innovation. The Safe Use Initiative welcomes proposals to this announcement which support its mission and goal.
- Read the details of the solicitation announcement (FDABAA-14-00120) (Open as of May 23, 2014)
- Please note Section 8.5
"8.5 Studies to increase the safety of post approval drug use"
"Develop innovative methods to better understand and reduce the occurrence of adverse events in post market use of drugs. Examples include but not limited to hypoglycemia in certain patient populations, serious bleeding in patients on anticoagulants, and patients in chronic pain on opioid therapy. Approaches could include the use of innovative messaging strategies, electronic health records, mobile technologies, clinical studies, or educational campaigns."